Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,877 public trials 1,785 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Study Evaluating HKI-272 in Tumors

NCT00146172

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • The Cleveland Clinic Foundation Taussig Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer

NCT01837095

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • St Luke's Cancer Institute Kansas City, Kansas, United States
  • Washington University School of Medicine, Division of Oncology St Louis, Missouri, United States
  • 'Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Weill Cornell Breast Center New York, United States
View Trial Details
Completed

Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women

NCT01923168

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI Birmingham, Alabama, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Los Angeles Hematology/Oncology Medical Group Onc Dept. Los Angeles, California, United States
  • University of California at Los Angeles UCLA SC Los Angeles, California, United States
View all 86 locations
View Trial Details
Completed

A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

NCT02019277

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • St George Hospital; Cancer Care Centre Kogarah, New South Wales, Australia
  • Port Macquarie Base Hospital Port Macquarie, New South Wales, Australia
  • Newcastle Mater Misericordiae Hospital; Oncology Waratah, New South Wales, Australia
  • Mater Hospital; Cancer Services South Brisbane, Queensland, Australia
View all 13 locations
View Trial Details
Completed

Cognition in the Study of Tamoxifen and Raloxifene

NCT00687102

Conditions
Aging, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • CCOP Western Regional Phoenix, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • Naval Hospital Camp Pendleton Camp Pendleton, California, United States
  • City of Hope National Medical Center Duarte, California, United States
View all 134 locations
View Trial Details

Related conditions